Alternatives to Denali Therapeutics

Developing novel therapeutics for neurodegenerative diseases using advanced biological insights.

Developing novel therapies for neurological disorders.

Restores glutamate homeostasis by targeting astrocyte biology, breaking the cycle of excitotoxicity across CNS diseases.

Developing a novel therapeutic approach for neurological disorders using advanced neuroimaging and AI.

A biotechnology company developing genetic therapies for rare disorders.

Biopharmaceutical company targeting neurodegeneration and aging by modulating the immune system.

Prophet Bio is a biotech startup focused on developing novel therapeutics for neurodegenerative diseases.

AI-guided drug discovery platform for tissue-targeted medicines.

Developing engineered biologics to harness the immune system for disease treatment.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Sinaptica Therapeutics is a biotechnology company developing novel therapies for neurodegenerative diseases, focusing on synaptic dysfunction.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Develops and manufactures biologics for therapeutic applications.

Developing novel therapeutics for challenging diseases using advanced biological insights.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Omega Therapeutics is developing a new class of programmable medicines called Epigenomic Controllers.

Clinical-stage company developing novel oncology therapies to overcome tumor immune evasion and drug resistance.

Mabylon is a biotechnology company focused on developing innovative antibody-based therapies for infectious diseases and cancer.

Developing novel therapeutics for rare and underserved diseases.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered platform for understanding disease biology and accelerating drug discovery.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Biopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

AI-driven drug discovery platform for rapid development of novel therapeutics.

Mapping cell-cell communication at scale in human tissue.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Biotech startup leveraging bat biology for novel therapeutics in immunology and cardiometabolic diseases.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Developing novel protein engineering tools for advanced biomanufacturing and therapeutics.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Biotech company developing novel therapeutics for fibrotic diseases.

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Diversified biopharmaceutical company focused on rare diseases and generics.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

AI-powered drug discovery and development platform for biologics.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Drug discovery platform focused on developing therapeutics for age-related diseases.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.